588 related articles for article (PubMed ID: 29465363)
21. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 17 regulates SHP-2 and IL-17RA/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis.
Ganesan R; Rasool M
Mol Immunol; 2017 Nov; 91():134-144. PubMed ID: 28898718
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study.
Chen Z; Cheng Z; Tang Z; Li M; Tang X; Zhang H; Sun L
Clin Exp Rheumatol; 2023 Nov; 41(11):2151-2161. PubMed ID: 36995338
[TBL] [Abstract][Full Text] [Related]
24. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of TAK-242 (Resatorvid) Effects on Inflammatory Status of Fibroblast-like Synoviocytes in Rheumatoid Arthritis and Trauma Patients.
Karami J; Farhadi E; Delbandi AA; Shekarabi M; Tahmasebi MN; Sharafat Vaziri A; Akhtari M; Mousavi MJ; Jamshidi A; Mahmoudi M
Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):453-464. PubMed ID: 34418899
[TBL] [Abstract][Full Text] [Related]
26. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
Choe JY; Park KY; Park SH; Lee SI; Kim SK
Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
[TBL] [Abstract][Full Text] [Related]
27. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.
Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH
Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893
[TBL] [Abstract][Full Text] [Related]
28. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Cho ML; Lee SH
PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998
[TBL] [Abstract][Full Text] [Related]
29. Osteoblastic NF-κB pathway is involved in 1α, 25(OH)2D3-induced osteoclast-like cells formation in vitro.
Cong L; Zhang C; Tu G
Int J Clin Exp Pathol; 2015; 8(5):5988-96. PubMed ID: 26191332
[TBL] [Abstract][Full Text] [Related]
30. Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways.
Li CH; Ma ZZ; Jian LL; Wang XY; Sun L; Liu XY; Yao ZQ; Zhao JX
Int Immunopharmacol; 2021 Jan; 90():107219. PubMed ID: 33307512
[TBL] [Abstract][Full Text] [Related]
31. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
Lee HY; Jeon HS; Song EK; Han MK; Park SI; Lee SI; Yun HJ; Kim JR; Kim JS; Lee YC; Kim SI; Kim HR; Choi JY; Kang I; Kim HY; Yoo WH
Arthritis Rheum; 2006 Jun; 54(6):1747-58. PubMed ID: 16736517
[TBL] [Abstract][Full Text] [Related]
32. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.
Li CH; Xu LL; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Yang L; Xing R; Liu XY
Inflamm Res; 2016 Mar; 65(3):193-202. PubMed ID: 26621504
[TBL] [Abstract][Full Text] [Related]
33. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis.
Fan LY; He DY; Wang Q; Zong M; Zhang H; Yang L; Sun LS
Scand J Rheumatol; 2012 Oct; 41(5):354-8. PubMed ID: 22765310
[TBL] [Abstract][Full Text] [Related]
34. Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis.
Samarpita S; Rasool M
Cytokine; 2021 Jun; 142():155502. PubMed ID: 33810944
[TBL] [Abstract][Full Text] [Related]
35. Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF-κB pathways.
Ni S; Li C; Xu N; Liu X; Wang W; Chen W; Wang Y; van Wijnen AJ
J Cell Physiol; 2018 Jan; 234(1):454-463. PubMed ID: 29932210
[TBL] [Abstract][Full Text] [Related]
36. Ameloblastin and enamelin prevent osteoclast formation by suppressing RANKL expression via MAPK signaling pathway.
Chaweewannakorn W; Ariyoshi W; Okinaga T; Morikawa K; Saeki K; Maki K; Nishihara T
Biochem Biophys Res Commun; 2017 Apr; 485(3):621-626. PubMed ID: 28161637
[TBL] [Abstract][Full Text] [Related]
37. TWEAK promotes osteoclastogenesis in rheumatoid arthritis.
Park JS; Kwok SK; Lim MA; Oh HJ; Kim EK; Jhun JY; Ju JH; Park KS; Park YW; Park SH; Kim HY; Cho YG; Cho ML
Am J Pathol; 2013 Sep; 183(3):857-67. PubMed ID: 23845567
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL.
Xing R; Zhang Y; Li C; Sun L; Yang L; Zhao J; Liu X
Int J Mol Med; 2016 Oct; 38(4):1125-34. PubMed ID: 27599586
[TBL] [Abstract][Full Text] [Related]
39. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH
Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
